Key Record Dates
ClinicalTrials.gov Identifier: | NCT05403385 |
---|---|
Brief Title: | Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer |
First Submitted : | May 18, 2022 |
First Submitted that Met QC Criteria : | May 31, 2022 |
First Posted : | June 3, 2022 |
Last Update Submitted that Met QC Criteria : | September 20, 2023 |
Last Update Posted : | September 21, 2023 |